# A Study of JNJ-63733657 in Healthy Chinese Participants

> **NCT05407818** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-63733657

## Key facts

- **NCT ID:** NCT05407818
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-27
- **Primary completion:** 2022-08-02
- **Final completion:** 2022-11-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05407818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05407818, "A Study of JNJ-63733657 in Healthy Chinese Participants". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05407818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*